News
The US Food and Drug Administration Has Declined to Approve Antidepressant ... - Latest Tweet by IANS India
The latest Tweet by IANS India states, 'The US Food and Drug Administration has declined to approve antidepressant fluvoxamine as a treatment for #COVID19 as data is insufficient to conclude its effectiveness against the virus.'
The US Food and Drug Administration (@US_FDA) has declined to approve antidepressant fluvoxamine as a treatment for #COVID19 as data is insufficient to conclude its effectiveness against the virus. pic.twitter.com/Rm6Wwk5sBE— IANS (@ians_india) May 17, 2022
(The above story first appeared on LatestLY on May 17, 2022 06:54 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
